Project Grant HT94252310898
Award Date 8/15/23
Completion Date 8/14/27
Dollars Obligated $637K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
- The Defense Health Agency has awarded a $893,000 Project Grant to the University of California, Los Angeles (UCLA) - Office of Research Administration to conduct research under the Military Medical Research and Development program (CFDA 12.420). This four-year grant, effective August 15, 2023 through August 14, 2027, will support UCLA's efforts to investigate the EGFR signaling network in glioblastoma, an aggressive form of brain cancer. As the prime grantee, UCLA will leverage its research...
- The University of California, Los Angeles (UCLA), through its Office of Research Administration, has been awarded a $2,351,564.00 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. This four-year grant, with a period of performance from August 15, 2023 to August 14, 2027, will support research targeting the EGFR signaling network in glioblastoma. As the prime grantee, UCLA will leverage its research facilities, faculty...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $557,438 project grant to the University of California, Los Angeles (UCLA) to investigate UCHL1 as a novel minimally invasive molecular indicator and therapeutic target for small cell lung cancer. This 2-year research project runs from September 15, 2023 to September 14, 2025 and will be conducted through UCLA's Office of Research Administration division. As a prime grantee, UCLA has also...
- The Defense Health Agency awarded the University of California, Los Angeles (UCLA) a $250,000 Project Grant titled "Probing Oligodendrocyte Lineage Cell Autocrine Signals to Treat Multiple Sclerosis" under the Military Medical Research and Development program (CFDA 12.420). This two-year grant, with a performance period from August 15, 2023 to August 14, 2025, supports UCLA's research to investigate treatment approaches for multiple sclerosis by studying autocrine signaling in...
- The Defense Health Agency has awarded a $1,626,500.00 Project Grant to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development program (CFDA 12.420). This grant, awarded on September 15, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant funds a range of research initiatives across medical domains such as cancer, neuroscience, infectious diseases, and...
- The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a four-year $596,016 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCLA's research into "ENVIRONMENTAL AND GUT-BRAIN AXIS DETERMINANTS OF COGNITIVE OUTCOMES IN PD" from September 1, 2023 through August 31, 2027. As the prime awardee, UCLA will leverage its research expertise and...
- This $235,476.00 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of California, Los Angeles (UCLA) in developing new cell-mediated immunotherapeutic strategies for neuroendocrine prostate cancer. The 2-year project, which began on November 1, 2025, aims to transform healthcare for military service members, veterans, and the broader public through innovative and impactful biomedical research....
- The University of California, Los Angeles (UCLA) was awarded a $2,162,723.00 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) for the project "CEREBELLAR NEUROMODULATION TO REDUCE COGNITIVE DYSFUNCTION AFTER MULTIPLE SUBCONCUSSIVE IMPACTS." The award period is from September 30, 2025 through September 29, 2029. The project aims to conduct advanced biomedical research to transform healthcare for military service members,...
- This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
- The University of California, Los Angeles (UCLA) has been awarded a $626,081 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program, administered by the Defense Health Agency. The grant, titled "Combinatorial Phenotype-Targeted Therapy to Overcome Mechanisms Driving Prostate Cancer Treatment Resistance," will support advanced biomedical research to transform healthcare for military service members and the broader public. The research...